| 000 | 03498nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 81659 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040340.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 151103s2015 ne | s |||| 0|eng d | ||
| 020 | _a9789401772150 | ||
| 024 | 7 |
_a10.1007/978-94-017-7215-0 _2doi |
|
| 050 | 4 |
_aRC267 _b.A383 2015 |
|
| 245 | 1 | 0 |
_aAdvances in Cancer Biomarkers : _bFrom biochemistry to clinic for a critical revision _cedited by Roberto Scatena. |
| 250 | _a1st ed. 2015. | ||
| 260 |
_aDordrecht, Netherlands _bSpringer _c2015 |
||
| 300 |
_a1 recurso en línea (IX, 372 páginas) _b27 ilustraciones, 21 ilustraciones en color |
||
| 336 |
_aTexto _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aAdvances in Experimental Medicine and Biology _x0065-2598 _v867 |
|
| 505 | 0 | _aPrelims -- IÂ{u796E}nerality.-Â{u9260} Tumor markers-a critical revision -- Enzymes.-Â{u8BF2}rmones -- Oncofetal proteins.-Â{u3E74}tokeratins -- Carbohydrate markers -- Blood group antigens.-Â{u796E}netic markers -- Various protein markers -- IIIÂ{u0972}spectives.-Â{u4A25} role of Circulating tumor Cells as tumor markers -- Index. | |
| 520 | 3 | _aAt present there are a growing number of biomolecules under investigation to understand their potential role as cancer biomarker for diagnostic, prognostic and therapeutic purposes.Â{u026E}triguingly, the state of art on cancer biomarkers research shows interesting and promising results together to clamorous failures. Also from a clinical point of view, there are contradictory results on routine clinical use of the present cancer biomarkers. Some patients may be simplyÂ{u0B6F}nitored in their course by a periodic blood sample, but sometimes this monitoring shows dramatic limits. A lot of patients show serious and extensive relapses without significant change in serum concentrations of biomarkers tested. Often the physician who should utilize these biomarker does not entirelyÂ{u0AEE}ow their limits and the total potential applications as well and sometimes this knowledge is influenced by economical and marketing strategies. This limited and “pollutedâ€{u0AEE}owledge may have dramatic consequences for patient.The aim of this book is to diffuse all aspects of cancer biomarkers, from their biochemical peculiarities to all clinical implications by passing through their physiology and pathophysiology. This critical approach towards old and new cancer biomarkers should foster a deepened and useful understanding of the diagnostic and prognostic index of these fundamental parameters of laboratory medicine and in the same time facilitating the research of new and more sensitive-specific signals of the cancer cell proliferation. | |
| 710 | 2 |
_aSpringerLink (Online service) _0Local _9106996 |
|
| 942 |
_2lcc _cLE |
||
| 988 | _aEBOOK, asignarmaterias, EBSPRINGER, | ||
| 650 | 2 | 7 |
_aFarmacología _2embne _9137893 |
| 650 | 7 |
_aFarmacología _2embne _9137893 |
|
| 700 | 1 |
_aScatena, Roberto _eeditor literario _994214 _0Local |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-7215-0 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12902494 _b10-10-17 _c18-01-16 |
||
| 998 |
_am _a_alco _a_vill _b - - _cm _dz _e- _feng _gne _h0 |
||
| 945 |
_aRC267 .A383 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11572115 _z06-04-17 |
||
| 999 |
_c81659 _d81659 _x1 |
||